Epstein-Barr Virus Market is driven by rising disease prevalence
The Epstein-Barr Virus (EBV) Market encompasses a range of diagnostic assays, prophylactic vaccines, antiviral agents, and emerging immunotherapeutic platforms designed to detect, prevent, and treat infections caused by EBV. Diagnostic products include serology-based enzyme-linked immunosorbent assays (ELISAs), polymerase chain reaction (PCR) kits, and next-generation sequencing tools capable...
0 Comments 0 Shares 235 Views 0 Reviews